This ESC position statement provides guidance on genetic counselling, family screening, and genetic testing for patients with cardiomyopathies and their families.
Advances in molecular genetics present new opportunities and challenges for cardiologists who manage patients and families with cardiomyopathies. The aims of this position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases are to review the general issues related to genetic counselling, family screening and genetic testing in families with a cardiomyopathy, and to provide key messages and suggestions for clinicians involved in their management.
Charron et al. (Tue,) studied this question.